Colorectal Cancer New Indication: Sotorasib with Panitumumab in kRAS G12C Mutated Colorectal Cancer Ulas D. Bayraktar, MD 2023-11-20
Colorectal Cancer New Protocol: Trifluridine-Tipiracil and Panitumumab for Refractory RAS WT Colorectal Cancer Ulas D. Bayraktar, MD 2023-09-23
Colorectal Cancer New Indication: Avelumab for MSI-High Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-08-20
Colorectal Cancer New Protocl: Trifluridine-Tipiracil and Bevacizumab in Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-05-20
Colorectal Cancer New Drug: Adagrasib with/without Cetuximab in kRAS G12C Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Protocol: Tucatinib and Trastuzumab for Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Indication: Encorafenib, Binimetinib, and Cetuximab for bRAF V600E Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Indication: Pembrolizumab for MSI-High Colorectal Cancer Ulas D. Bayraktar, MD 2022-07-16
